In START, SAA was also found to be strongly correlated with biomarkers of vascular inflammation including hsCRP, sICAM and sVCAM, which translated into an increased risk of AIDS‐related events in participants who had higher concentrations of SAA 24. The gene discussed is SAA1; the disease is AIDS.